XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Common Share And Share Awards Summary Of Share-Based Award Transactions (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, SARS, Outstanding [Roll Forward]              
Number Of Shares, SARs granted 5   4 7      
SARs              
Share-based Compensation Arrangement by Share-based Payment Award, SARS, Outstanding [Roll Forward]              
Number Of Shares, Outstanding Beginning Balance   36   30 36 30  
Number Of Shares, SARs granted   0     5 14  
Number Of Shares, SARS exercised         (3) (8)  
Number Of Shares, Outstanding Ending Balance         38 36 30
Number Of Shares, Exercisable as of September 30, 2021         29    
Number Of Shares, Unvested as of September 30, 2021         9    
Share-based Compensation Arrangement by Share-based Payment Award, SARs, Outstanding, Weighted Average Exercise Price [Roll Forward]              
Weighted Average Exercise Price, Outstanding Beginning Balance   $ 139.16   $ 124.13 $ 139.16 $ 124.13  
Weighted Average Exercise Price, SARs granted         184.26 137.40  
Weighted Average Exercise Price, SARS exercised         68.70 75.75  
Weighted Average Exercise Price, Outstanding Ending Balance         150.06 $ 139.16 $ 124.13
Weighted Average Exercise Price, Exercisable as of September 30, 2021         149.50    
Weighted Average Exercise Price, Unvested as of September 30, 2021         $ 151.80    
Average Remaining Contractual Term, Outstanding Beginning Balance         4 years 3 months 21 days 4 years 4 months 17 days 3 years 6 months 10 days
Average Remaining Contractual Term, Outstanding Ending Balance         4 years 3 months 21 days 4 years 4 months 17 days 3 years 6 months 10 days
Average Remaining Contractual Term, Exercisable as of September 30, 2021         3 years 9 months 7 days    
Average Remaining Contractual Term, Unvested as of September 30, 2021         5 years 11 months 15 days    
Aggregate Intrinsic Value, Outstanding Beginning Balance   $ 903   $ 1,352 $ 903 $ 1,352  
Aggregate Intrinsic Value, Outstanding Ending Balance         1,317 $ 903 $ 1,352
Aggregate Intrinsic Value, Exercisable as of September 30, 2021         1,028    
Aggregate Intrinsic Value, Unvested as of September 30, 2021         $ 289